SCHEMBL5169910

SCHEMBL5169910

NC1(S(=O)(=O)O)CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
CYP2C19 P33261 1/20 0.39
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
NT5E P21589 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA5A P35218 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30
CA5B Q9Y2D0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690466 0.97 TSHR (0.35) TSHRCYP2C19CA1CA2NT5E
SCHEMBL27525935 0.85
SCHEMBL11288936 0.77 TSHR (0.36) TSHRCYP2C19CA1CA2
SCHEMBL3100846 0.77 TSHR (0.36) TSHRCYP2C19CA1CA2
SCHEMBL27772667 0.74 TSHR (0.35) TSHRCYP2C19CA1CA2
SCHEMBL27229156 0.72 TSHR (0.33) TSHRCYP2C19CA1
Sulfuric Acid SCHEMBL5465130 0.72 TSHR (0.39) TSHRCYP2C19CA1CA2NT5E
SCHEMBL28059858 0.71 GAA (0.36) TSHRCYP2C19
SCHEMBL11452245 0.71 GAA (0.36) TSHRCYP2C19
SCHEMBL8319769 0.69 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118251210-A Dissolution test 爱尔兰詹森科学公司 2024-06-25 CN disclosed
CN-118076602-A Heteroaryl-acetylenes, pharmaceutical compositions thereof and their therapeutic uses 嘉兴优博生物技术有限公司 2024-05-24 CN disclosed
CN-115516044-B Fluorescent dimer compounds useful as probes for detection of endogenous receptors 斯特拉斯堡大学 2024-05-14 CN disclosed
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 CN disclosed
CN-116848102-A Crystalline CSF-1R inhibitor acid salt and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-10-03 CN disclosed
CN-116783165-A 1,2,3, 4-tetrahydroquinoline derivatives as YAP/TAZ-TEAD activation inhibitors for the treatment of cancer 天主教鲁汶大学 2023-09-19 CN disclosed
CN-116744928-A Quinolines modulating SERCA and their use for treating diseases 神经元公司 2023-09-12 CN disclosed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 CN disclosed
CN-116437901-A Treatment or prevention of diseases or conditions 爱尔兰詹森科学公司 2023-07-14 CN disclosed
CN-116437923-A Treatment or prevention of HIV infection 爱尔兰詹森科学公司 2023-07-14 CN disclosed
EP-1773916-B1 PROCESS FOR PREPARATION OF FUNCTIONALIZED POLYIMIDES SABIC INNOVATIVE PLASTICS IP (NL) 2014-02-12 EP disclosed
CN-101010359-B Process for preparation of functionalized polyimides SABIC INNOVATIVE PLASTICS IP 2012-07-11 CN disclosed
CN-101010359-A Process for preparation of functionalized polyimides GEN ELECTRIC (US) 2007-08-01 CN disclosed
EP-1773916-A1 PROCESS FOR PREPARATION OF FUNCTIONALIZED POLYIMIDES The General Electric Company (US) 2007-04-18 EP disclosed
US-7148314-B2 Process for preparation of functionalized polyimides GENERAL ELECTRIC COMPANY (US) 2006-12-12 US disclosed
WO-2006014448-A1 PROCESS FOR PREPARATION OF FUNCTIONALIZED POLYIMIDES GENERAL ELECTRIC COMPANY (US) 2006-02-09 WO disclosed
US-20060009613-A1 Process for preparation of of functionalized polyimides GENERAL ELECTRIC COMPANY 2006-01-12 US disclosed